Purchase Order 75N91024P00332
Award Date
6/25/24
Potential Completion Date
6/24/25
Potential Value
$14K
Federal Agency
National Cancer Institute
Awardee
Molecular Devices LLC
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal purchase order awarded by the National Institutes of Health (NIAID DEA OA Acquisitions) to Molecular Devices LLC, a subsidiary of Danaher Corporation, for the provision of a SPECTRAMAX I3 MULTI-MODE MICROPLATE DETECTION PLATFORM and an annual maintenance agreement. The contract has a firm-fixed price of $62,197.00 and a completion date of May 6, 2015. There was no set-aside used for this award. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a service agreement with a potential value of $10,217.00. The contract does not have a set-aside designation and is scheduled for completion on June 8, 2025. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, such as...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH,...
This firm-fixed-price purchase order for $41,597.00 was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the delivery of a SpectraMax iD5 Standard Multimode Microplate Detection Platform, a specialized laboratory instrument used in life science research and drug discovery. Molecular Devices LLC is a manufacturer of high-performance...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a Firm Fixed Price purchase order to Molecular Devices LLC, a subsidiary of Danaher Corporation, for a Service and Maintenance Agreement on a Molecular Devices M5 plate reader. The award has a potential value of $18,218.00 and a completion date of January 19, 2024. This contract does not have a set-aside designation. Molecular Devices is a provider of bioanalytical measurement...
This is a firm-fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for a service maintenance plan for a SpectraMax M3 Multimode Reader. The contract has a ceiling value of $54,173.00 and a completion date of August 7, 2025. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contract awards from agencies...
This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $7,332.00, is for a service plan for a SpectraMax M5 microplate reader system. This award does not have a set-aside designation. Molecular Devices LLC is a leading provider of bioanalytical measurement...
This federal contract award to Molecular Devices LLC, a division of Danaher Corporation, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the purchase of a SpectraMax ID3 microplate reader. The $24,768.00 firm-fixed-price purchase order does not have a set-aside designation. Molecular Devices is a leading provider of high-performance bioanalytical measurement solutions for life science research,...
This is a $7,529.25 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for annual service and maintenance of the SpectraMax M2 microplate reader system used in NCI's research programs. The contract has an ultimate completion date of March 31, 2025 and was awarded on April 14, 2020. There is no set-aside designation for this award. Molecular Devices LLC is the prime contractor and...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services. The $57,545.00 contract is for a service agreement to provide laboratory equipment from Molecular Devices LLC, a division of Danaher Corporation. The contract does not have a set-aside designation and has an ultimate completion date of October 31, 2023. Molecular Devices LLC, as the...